MEF2C News — MEF2C Research: Explained Simply

Latest Research & News

We track MEF2C haploinsufficiency news and research across all of our wonderful foundations, research centres, trials, and papers. Then we attempt to explain it as plainly as possible for the community.

Filter by:

Clinical Trials

New Brain-Penetrant CDK2 Inhibitor Begins Human Trials

On May 29, 2026, the first patient was dosed with AL-605, a new CDK2 inhibitor developed by Alaw Therapeutics, in a clinical trial. Here's why that's important for MEF2C...

2026-06-13

Foundation News

MEF2C Community Roundup: Fundraising, Registry Growth and Global Awareness

While scientific breakthroughs often capture the headlines, they rarely happen in isolation.

2026-06-13

Historical

MEF2C and the Developing Brain

Between 2012 and 2014, multiple research groups revealed how losing one copy of MEF2C causes such profound neurological damage.

2026-06-09

Research

MEF2C Regulates Both Early Development and Late-Life Brain Health

Two recent studies, seemingly unrelated at first glance, offer profound new insights into the gene MEF2C, shedding light on its roles in heart development, brain immunity, and the consequences for individuals with MEF2C Haploinsufficiency Syndrome (MCHS).

2026-06-09

Foundation News

From Sydney to New York: MEF2C Foundation Australia Leads the Global Charge

MEF2C Foundation Australia is at the frontline of the Volare Study, the first longitudinal natural history study for MCHS.

2026-06-09

Foundation News

Milestone Numbers: US MEF2C Foundation Registry Reaches 170 Patients

The US MEF2C Foundation has reached a critical data threshold, with 170 patients now registered in the foundation's registry. This growing longitudinal dataset is fueling the path toward human clinical trials for MEF2C Haploinsufficiency Syndrome.

2026-06-08

Historical

Naming the Unnameable: The Emergence of MEF2C Haploinsufficiency Syndrome

For countless families, the journey for their child struggling with unexplained developmental delays, epilepsy, or severe movement impairment often reached a critical point: moving from a world of frustration with "we don't know" to a moment of nascent hope with "now we have a name."

2026-06-01